Call us directly: +44 (0)7905 201857

Email us

Members log in

Apr 5

BigB2SME event with Johnson & Johnson Innovation – 3rd May, London

London MedTech Banner

SEHTA, GLA and MedCity would like to invite you to register your interest to attend the next MedTech London BigB2SME event, this time with Johnson & Johnson Innovation, which is designed to build bridges between small companies (including MedTech, University and NHS Technologists) and Johnson & Johnson Innovation.

Date: Thursday 3rd May

Venue: City Hall, London

Times: 10:00 – 15:00

Cost: Free of charge


  • Do you want to understand more about how to work with multinational health technology companies?
  • Is a partnership or other commercial agreement with a large multinational company something you should consider to help develop your business?
  • Are you developing a technology, product or service in?

Orthopaedics – earlier interventions in degenerative diseases, e.g. osteoarthritis, osteoporosis, degenerative disc disease

General & orthopaedics – technologies to support pre-operative planning, intra-operative navigation and visualisation

Obesity – More durable interventions across the continuum, which also prevent or reduce morbidities of obesity




Please note places are limited and applications will be reviewed based on London-focus and offer.  Places will be confirmed no later than Friday 20th April.



10:00 – 10:30  Registration and Refreshments

10:30 – 10:35  Welcome, Dr David Parry, CEO, SEHA

10:35- 10:40   Introduction to the Johnson & Johnson Innovation team

10:40 – 11:10  An overview of Johnson & Johnson Innovation including the Innovation Centres, JJDC and JLABs, Dr Mirren Mandalia, Senior Director, New Ventures & Transactions (Medical Devices), Johnson & Johnson Innovation

11:10- 11:40  Focus areas for Johnson & Johnson Medical Devices, Dr Mirren Mandalia, Senior Director, New Ventures & Transactions (Medical Devices), Johnson & Johnson Innovation

11:40 – 12:00  Q&A

12:00 – 15:00  Networking and Refreshments (Lunch is not being provided, but the Café at City Hall is available to buy lunch)

12:30 – 15:00 Pre-arranged 1:1 sessions with Johnson & Johnson representatives and selection for follow-up.  Each 1:1 session lasts for 15 mins and you can book your 1:1 slot when you register your interest.  Sessions available with:

  • Dr Mirren Mandalia, Senior Director, New Ventures & Transactions (Medical Devices),Johnson & Johnson Innovation
  • Dr Michael Ullmann, Innovation Director, Medical Devices DACH, Johnson & Johnson Innovation
  • Dr Nicoline Van Leersum, Innovation Director, Medical Devices Benelux, Johnson & Johnson Innovation


Supported by: jnj_innovation_logo_horizontal_RGB